Clinical Utility Gene Card For: Multiple Endocrine Neoplasia Type 2

Overview

Journal Eur J Hum Genet

Specialty Genetics

Date 2011 Aug 25

PMID 21863057

Citations 1

Authors

Friedhelm Raue

Susanne Rondot

Egbert Schulze

Sylwia Szpak-Ulczok

Barbara Jarzab

Karin Frank-Raue

Affiliations

Soon will be listed here.

Citing Articles

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

Oczko-Wojciechowska M, Swierniak M, Krajewska J, Kowalska M, Kowal M, Stokowy T Sci Rep. 2017; 7:42074.

PMID: 28181547 PMC: 5299608. DOI: 10.1038/srep42074.

References

de Groot J, Links T, Plukker J, Lips C, Hofstra R . RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev. 2006; 27(5):535-60. DOI: 10.1210/er.2006-0017. View

Hansford J, Mulligan L . Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet. 2000; 37(11):817-27. PMC: 1734482. DOI: 10.1136/jmg.37.11.817. View

Kloos R, Eng C, Evans D, Francis G, Gagel R, Gharib H . Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009; 19(6):565-612. DOI: 10.1089/thy.2008.0403. View

Pacak K, Eisenhofer G, Ilias I . Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome. Hormones (Athens). 2009; 8(2):111-6. PMC: 4713023. DOI: 10.14310/horm.2002.1227. View

Raue F, Kraimps J, Dralle H, Cougard P, Proye C, Frilling A . Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med. 1995; 238(4):369-73. DOI: 10.1111/j.1365-2796.1995.tb01212.x. View

Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E . RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab. 2007; 92(12):4725-9. DOI: 10.1210/jc.2007-1005. View

Brooks A, Oostra B, Hofstra R . Studying the genetics of Hirschsprung's disease: unraveling an oligogenic disorder. Clin Genet. 2004; 67(1):6-14. DOI: 10.1111/j.1399-0004.2004.00319.x. View

Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven T, Roeher H . Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med. 2003; 349(16):1517-25. DOI: 10.1056/NEJMoa012915. View

Frank-Raue K, Rondot S, Raue F . Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC. Mol Cell Endocrinol. 2010; 322(1-2):2-7. DOI: 10.1016/j.mce.2010.01.012. View

10.

Dora J, Canalli M, Capp C, Punales M, Vieira J, Maia A . Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid. 2008; 18(8):895-9. DOI: 10.1089/thy.2007.0231. View

11.

Frank-Raue K, Rybicki L, Erlic Z, Schweizer H, Winter A, Milos I . Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Hum Mutat. 2010; 32(1):51-8. DOI: 10.1002/humu.21385. View

12.

Raue F, Frank-Raue K . Update multiple endocrine neoplasia type 2. Fam Cancer. 2010; 9(3):449-57. DOI: 10.1007/s10689-010-9320-2. View

13.

Wiench M, Wygoda Z, Gubala E, Wloch J, Lisowska K, Krassowski J . Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients. J Clin Oncol. 2001; 19(5):1374-80. DOI: 10.1200/JCO.2001.19.5.1374. View

14.

Wang T, Ocal I, Sosa J, Cox H, Roman S . Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid. 2008; 18(8):889-94. DOI: 10.1089/thy.2007.0413. View

15.

Brandi M, Gagel R, Angeli A, Bilezikian J, Beck-Peccoz P, Bordi C . Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001; 86(12):5658-71. DOI: 10.1210/jcem.86.12.8070. View

16.

Romei C, Mariotti S, Fugazzola L, Taccaliti A, Pacini F, Opocher G . Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol. 2010; 163(2):301-8. DOI: 10.1530/EJE-10-0333. View